Advertisement

Topics

Sucampo Pharmaceuticals, Inc. and Takeda Company Profile

17:03 EDT 20th September 2018 | BioPortfolio

Sucampo Pharmaceuticals, Inc., an international pharmaceutical company, is focused on the discovery, development and commercialization of proprietary drugs based on prostones. The therapeutic potential of prostones, which occur naturally in the human body as a result of enzymatic (15-PGDH) transformation of certain fatty acids, was first identified by Ryuji Ueno, M.D., Ph.D., Ph.D., Sucampo Pharmaceuticals' Chairman and Chief Executive Officer. Dr. Ueno founded Sucampo Pharmaceuticals in 1996 with Sachiko Kuno, Ph.D., founding Chief Executive Officer and currently Advisor, International Business Development, and a member of the Board of Directors. For more information, please visit www.sucampo.com.


News Articles [885 Associated News Articles listed on BioPortfolio]

Deals and M&As this week: Aralez Pharmaceuticals, Perrigo, Takeda

Aralez Pharmaceuticals has entered two purchase agreements to sell its main operating businesses, Vimovo and Toprol-XL, for $250m. The two...Read More... The post Deals and M&As this week: Aralez...

20152023 World Irritable Bowel Syndrome IBS Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 16022018] Prices from USD $2800

SummaryxxxThis report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and...

Japanese drug maker Takeda agrees to buy Ireland's Shire

Japanese drugmaker Takeda has agreed to buy Shire Plc for 46 billion pounds in cash and stock - one of the biggest deals ever in the pharmaceuticals industry, the companies said in statements Tuesday....

Rhythm Pharmaceuticals buys global rights to Takeda drug

Rhythm Pharmaceuticals purchased exclusive global rights to Takeda's T-3525770, now known as RM-853, an oral inhibitor of the -More- 

The Big Tease: Takeda Considers Buying Shire

Shire stock prices jumped up to 26 percent on rumors that Takeda Pharmaceuticals was considering a buyout.

STAT Plus: Pharmalittle: Express Scripts targets new migraine drugs; Takeda edges closer to a deal for Shire

Takeda Pharmaceuticals is nearing a preliminary agreement to acquire Shire after sweetening its roughly $60 billion bid.

Ahead of the Takeda-Shire Takeover, Takeda Selling Chinese Joint Venture

With the acquisition of Dublin-based Shire by Japan-based Takeda Pharmaceutical pretty much a done-deal, Takeda appears to be getting its financial house in order before it closes.

STAT Plus: Pharmalittle: Pharma gives big bucks to patient groups; did Takeda CEO play favorites?

Takeda Pharmaceuticals chief executive officer Christophe Weber told a select audience of analysts from UBS Group and Credit Suisse that the company is contemplating a deal for Shire.

Drugs and Medications [286 Associated Drugs and Medications listed on BioPortfolio]

Prevacid [Novartis Consumer Health, Inc.]

PREVACID 24 HRLansoprazole delayed-release capsules 15mg / acid reducer

Edarbi [Takeda Pharmaceuticals America, Inc.]

These HIGHLIGHTS do not include all the information needed to use EDARBI safely and effectively. See full prescribing information for EDARBI. Edarbi (azilsartan medoxomil) tabletsInitial U.S. Approval...

Lupron depot ped [Takeda Pharmaceutical Company LTD]

LUPRON DEPOT-PED (leuprolide acetate for depot suspension) 7.5 mg, 11.25 mg and 15 mg

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

Actos [Takeda Pharmaceutical Co LTD]

ACTOS (pioglitazone hydrochloride) Tablets

PubMed Articles [149 Associated PubMed Articles listed on BioPortfolio]

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Measurement of three-dimensional wavefronts using the Ichikawa-Lohmann-Takeda solution to the irradiance transport equation.

In this paper, we use the irradiance transport equation and the Fourier transform-based experimental solution given by Ichikawa-Lohmann-Takeda. We analyze experimental factors such as the digital filt...

Swimming activity in zebrafish larvae exposed to veterinary antiparasitic pharmaceuticals.

Veterinary antiparasitic pharmaceuticals have been detected in surface waters and several of these pharmaceuticals act on the nervous system on the target organisms implying that neurological effects ...

Assessment of 83 pharmaceuticals in WWTP influent and effluent samples by UHPLC-MS/MS: Hourly variation.

The removal efficiency of pharmaceuticals in wastewater treatment plants (WWTPs) is variable and some of these compounds pass these plants almost intact and others presenting a removal efficiency clos...

Post-production handling and administration of protein pharmaceuticals and potential instability issues.

The safety and efficacy of protein pharmaceuticals depend not only on biological activity, but also on purity levels. Impurities may be process related due to limitations in manufacturing, or product ...

Clinical Trials [229 Associated Clinical Trials listed on BioPortfolio]

A Bioequivalence Study of Dexlansoprazole From Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant 60 mg Delayed Release (DR) Capsules (Takeda Pharmaceuticals America Inc., USA)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Dexlansoprazole from Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant...

Bioequivalence Study of Dexlansoprazole Capsules From Two Manufacturing Plants

The purpose of this study is to assess the bioavailability of dexlansoprazole from a 30 milligram (mg) or 60 mg delayed-release capsule manufactured at Takeda GmbH Plant Oranienburg, Germa...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Companies [1356 Associated Companies listed on BioPortfolio]

Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A., Inc.

Sucampo Pharmaceuticals, Inc. is a global pharmaceutical company focused on innovative research, discovery, development and commercialization of proprietary drugs based on proston...

Sucampo Pharmaceuticals, Inc. and Takeda

Sucampo Pharmaceuticals, Inc., an international pharmaceutical company, is focused on the discovery, development and commercialization of proprietary drugs based on prostones. The...

Sucampo Pharmaceuticals, Inc. and Abbott

Sucampo Pharmaceuticals, Inc., an international biopharmaceutical company based in Bethesda, Maryland, focuses on the development and commercialization of medicines based on prost...

Sucampo Pharmaceuticals, Inc. and Numab AG

Sucampo Pharmaceuticals, Inc., an international pharmaceutical company based in Bethesda, Maryland, is focused on the discovery, development and commercialization of proprietary d...

Sucampo Pharmaceuticals, Inc.

About chronic idiopathic constipation

More Information about "Sucampo Pharmaceuticals, Inc. and Takeda" on BioPortfolio

We have published hundreds of Sucampo Pharmaceuticals, Inc. and Takeda news stories on BioPortfolio along with dozens of Sucampo Pharmaceuticals, Inc. and Takeda Clinical Trials and PubMed Articles about Sucampo Pharmaceuticals, Inc. and Takeda for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sucampo Pharmaceuticals, Inc. and Takeda Companies in our database. You can also find out about relevant Sucampo Pharmaceuticals, Inc. and Takeda Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record